Yifei Hu

6PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 11, 2026
Low-Strength Type I Interferon Signaling Promotes CAR T-cell Treatment Efficacy.

|Jun 04, 2025
Low-Strength Type I Interferon Signaling Promotes CAR T-Cell Treatment Efficacy.

Erting Tang, Yifei Hu, Guoshuai Cao

|May 06, 2025
Two-stage CD8+ CAR T-cell differentiation in patients with large B-cell lymphoma.

Guoshuai Cao, Yifei Hu, Tony Pan

|Sep 13, 2024
CD4+ T cells with convergent TCR recombination reprogram stroma and halt tumor progression in adoptive therapy.

Steven P Wolf, Matthias Leisegang, Madeline Steiner

|Feb 19, 2024
Multimodal probing of T-cell recognition with hexapod heterostructures.

Xiaodan Huang, Lingyuan Meng, Guoshuai Cao

|Apr 21, 2021
Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma.

Jonathan A Trujillo, James Godfrey, Yifei Hu

Pageof 1

Frequent Collaborators

6 joint publications

Jun Huang

2 joint publications

Peter A Riedell

2 joint publications

Guoshuai Cao

2 joint publications

Erting Tang